| 1Smigal C,Jemal A,Ward E,et al.Trends in breast cancer by race and ethnicity:update2006[J].CA Cancer J Clin,2006,56:168-183.
2Colonna M,Delafosse P,Uhry Z,et al.Is breast cancer incidence increasing among young women?An analysis of the trend in France for the period1983-2002[J].Breast,2008,17(3):289-292.
3Tarone RE.Breast cancer trends among young women in the United States[J].Epidemiology,2006,17:588-590.
4艾秀清,成芳,木妮热.木沙江.102例青年乳腺癌相关因素分析[J].中国肿瘤临床,2009,36(20):1145-1147.
5王中华,徐冰河.129例30岁以下女性乳腺癌临床特点及预后分析[J].中华肿瘤杂志,2005,2(27):111-113.
6诸林海,丁向民,王道荣.青年乳腺癌临床特征与预后的分析[J].中国现代普通外科进展,2007,10(06):484-486.
7张晨芳,康慧鑫,张宏,等.青年乳腺癌97例临床特点及预后分析[J].实用医学杂志,2006,22(120:1426-1427.
8Loman N,Johannsson O,Kristoffersson U,et al.Family history of breast and ovari-an cancers and BRCA1and BRCA2Mutations in a population-based series of early-onset breast cancer[J].J Nat Cancer Inst,2001,93:1215-1223.
9Longo D.Radiation in Hodgkin’s disease[J].J Nat Cancer Inst,2005,97:1394-1395.
10Mintzer D,Glassburn J,Mason BA,et al.Breast cancer in the very young patient[J].Oncologist,2002,7:547-554.
11Newman LA.Breast cancer in African-American women[J].Oncologist,2005,10:1-14.
12Kollias JEC,Ellis IO,Robertson JF,et al.Early-onset breast cancer:histopatho-logical and prognostic consideration[J].Br J Cancer,1997,75:1318-1323.
13Weber-Mangal S,Sinn HP,Popp S,et al.Breast cancer in young women(-35years):genomic aberrations detected by comparative genomic hybridization[J].Int J Cancer,2003,107:583-592.
14Braun S,Vogl FD,Naume B,et al.Apooled analysis of bone marrowmicrometas-tases in breast cancer[J].N Engl J Med,2005,353:793-802.
15Amend K,Hicks D,Ambrosone CB.Breast cancer in African-American women:differences in tumor biology from European-American women[J].Cancer Res,2006,66:8327-8230.
16Bollet MA,Sigal-Zafrani B,Mazeau V,et al.Age remains the first prognostic fac-tor for loco-regional recurrence in young women treated with breast conserving surgery first[J].Radiother Oncol,2007,82:272-280.
17Kolb TM,Lichy J,Newhouse JH.Comparison of the performance of screening mammography,physical exam,and breast ultrasound,and analysis of features that influence them:an analysis of27825patient evaluations[J].Radiology,2002,225:165-175.
18Pisano ED,Gatsonis C,Hendrick E,et al.Diagnostic performance of digital versus film mammography for breast cancer screening[J].N Engl J Med,2005,353:1773-1783.
19Houssami N,Irwig L,Simpson JM,et al.Sydney breast imaging accuracy study:comparative sensitivity and specificity of mammography and sonography in young women with symptoms[J].Am J Roentgenol,2003,180:935-940.
20Braun M,P lcher M,Schrading S.Influence of preoperative MRI on the surgical management of patients with operable breast cancer[J].Breast Cancer Res Treat,2008Sep,111(1):179-187.
21Vallow L,Packianathan S,Feigel D.Analysis of magnetic resonance imaging(MRI)in the detection of mammographically occult breast carcinoma[J].Jour-nal of Clinical Oncology,2007,25:603.
22Voogd AC,Nielsen M,Peterse JL,et al.Differences in risk factors for local and distant recurrence after breast conserving therapy or mastectomy for Stage I and Stage II breast cancer:pooled Results of two large European randomized trials[J].J Clin Oncol,2001,19:1688-1697.
23Zhou P,GautamS,RechtA.Factors affectingoutcome for youngwomen with early stage breast cancer treated with breastconserving therapy[J].Breast Cancer Res Treat,2007,101:51-57.
24Harry B,Jean-Claude H,Philip M,et al.Impact of a higher radiation dose on lo-cal control and survival in breast-conserving therapy of early breast cancer:10-year Results of the randomized boost versus no boost EORTC22881-10882trial[J].J Clin Oncol,2007,25:3259-3264.
25van-der LM,Evers L,van-der SMJC,et al.The safety of breast-conserving therapy in patients with breast cancer aged≤40years[J].Cancer,2007,109:1957-1964.
26Axelrod D,Smith J,Kornreich D.Breast cancer in young women[J].J Am Coll Surg,2008,206:1193-1203.
27Kaufmann M,Jonat W,Blarney R,et a1.survival analyses from the ZEBRAstudy goserelin(Zoladex)versus CMF in premenopausal women with node-positive breast cancer[J].Eur J Cancer,2003,39(12):1711-1717.
28Cuziek J,Ambroisine L,Davidson N,et al.Use of luteinising-hermone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer:a meta-analysis of individual patient data from randomised adjuvant trials[J].Lancet,2007,369(9574):1711-1723.
29HackshawA,Baum M,Fornander T,et al.Long-term effectiveness of adjuvant go-serelin in premenopausal women with early breastcancer[J].J Natl Cancer Inst,2009,101(5):341-349.
30Molckovsky A,Madarnas Y.Breast cancer in pregnancy:a literature review[J].Breast Cancer Res Treat,2008,108(3):333-338.
31Daling JR,Malone KE,Doody DR,et al.The relation of reproductive factors to mortality from breast cancer[J].Cancer Epidemiol Biomarkers Prev,2002,11:235-241.
32Kuerer H,Gwyn K,Ames FC,et al.Conservative surgery and chemotherapy for breast carcinoma during pregnancy[J].Surgery,2002,131:108-110.
33Berry DL,Theriault RL,Holmes FA,et al.Management of breast cancer during pregnancy using a standardized protocol[J].J Clin Oncol,1999,17:855-861.
34Hahn MEK,Johnson PH,Gordon N,etal.Treatmentof pregnantbreastcancer pa-tients and outcomes of children exposed to chemotherapy in utero[J].Cancer,2006,107:1219-1226. |
